BRG Research Shows Site-of-Care Shift For Physician-Administered Drug Therapies

In October 2017, BRG professionals published a white paper evaluating the breakdown in site of care for top physician administered drugs covered by Medicare Part B that are used to treat several conditions (e.g. breast cancer, rheumatoid arthritis, and multiple sclerosis). This paper by BRG Expert Eleanor Blalock is an update to prior analysis to reflect Medicare claims data through 2017 and provide a broader view of all Part B drugs. Click to read more.

MedPAC Hospital Recommendations For 2020

MedPAC recommends that Congress update Medicare inpatient and outpatient payment rates for 2020 by 2%. The Commission is also recommending a new hospital value incentive program (HVIP) that would replace the current quality incentive programs. This brief discusses these recommendations and other key highlights from the March MedPAC chapter on hospitals.  Click to read more.